You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TSC2

Showing 1 - 25 of 206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

Recruiting
  • Tuberous Sclerosis Complex
  • Epilepsy
  • Birmingham, Alabama
  • +7 more
Sep 2, 2022

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing
  • PEComa, Malignant
  • +3 more
  • (no location specified)
Mar 2, 2022

Malignant Solid Tumors Trial (Sirolimus for Injection (Albumin-bound))

Not yet recruiting
  • Malignant Solid Tumors
  • Sirolimus for Injection (Albumin-bound)
  • (no location specified)
Aug 19, 2022

Lymphangioleiomyomatosis (LAM) Trial in Boston (Celecoxib)

Completed
Has Results
  • Lymphangioleiomyomatosis (LAM)
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 18, 2022

Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))

Active, not recruiting
  • Tuberous Sclerosis Complex
  • Epilepsy
  • TAVT-18 (sirolimus)
  • Cincinnati, Ohio
    Cincinnati Children's Hospital
Jan 10, 2022

SARS-CoV-2 (Covid19) Trial in Bucharest (Trans Sodium Crocetinate, Normal saline)

Completed
Has Results
  • SARS-CoV-2 (Covid19)
  • Trans Sodium Crocetinate
  • Normal saline
  • Bucharest, Romania
    National Institute of Infectious Diseases- Prof. Dr. Matei Balş
Apr 12, 2022

TSC1, TSC2, Tuberous Sclerosis Complex Trial in Boston, New York (Everolimus)

Completed
Has Results
  • TSC1
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 14, 2020

Tuberous Sclerosis Trial in United States (Ganaxolone)

Completed
  • Tuberous Sclerosis
  • Los Angeles, California
  • +6 more
Oct 27, 2022

Stroke, Acute Trial in Los Angeles, Charlottesville (Trans-Sodium Crocetinate, Placebo)

Terminated
Has Results
  • Stroke, Acute
  • Trans-Sodium Crocetinate
  • Placebo
  • Los Angeles, California
  • +1 more
May 24, 2021

Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )

Completed
  • Facial Angiofibroma
  • Tuberous Sclerosis
  • Phoenix, Arizona
  • +16 more
Jul 26, 2022

Lymphangioleiomyomatosis Trial in Beijing (11C-Choline)

Not yet recruiting
  • Lymphangioleiomyomatosis
  • Beijing, Dongcheng, China
    Peking union medical college hospital
Oct 8, 2021

Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

Recruiting
  • Tuberous Sclerosis
  • Lymphangioleiomyomatosis
  • Phlebotomy
  • +3 more
  • Birmingham, Alabama
  • +22 more
Jan 6, 2023

Studies in Patients With Tuberous Sclerosis Complex

Recruiting
  • Tuberous Sclerosis Complex
    • Phoenix, Arizona
      Translational Genomics Research Institute (TGen)
    Oct 18, 2022

    Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2022

    Tuberous Sclerosis Complex Trial in Bristol (Acceptance and Commitment Therapy (ACT))

    Recruiting
    • Tuberous Sclerosis Complex
    • Acceptance and Commitment Therapy (ACT)
    • Bristol, United Kingdom
      University Hospitals Bristol and Weston NHS Trust
    May 10, 2023

    Lymphangioleiomyomatosis Trial in Milan (Nintedanib)

    Completed
    • Lymphangioleiomyomatosis
    • Milan, Italy
      Pneumology unit
    Sep 26, 2022

    Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

    Recruiting
    • Tuberous Sclerosis Complex
    • Basimglurant with crossover to Placebo
    • Placebo with crossover to Basimglurant
    • Phoenix, Arizona
    • +47 more
    Jan 3, 2023

    Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

    Active, not recruiting
    • Hypomelanotic Macules
    • +8 more
      • Tirana, Albania
      • +7 more
      Mar 23, 2022

      Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

      Not yet recruiting
      • Head and Neck Cancer
      • +20 more
      • TSC-204-A0201
      • +4 more
      • Scottsdale, Arizona
      • +1 more
      Aug 3, 2023

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +44 more
      • Biopsy
      • +23 more
      • Birmingham, Alabama
      • +166 more
      Feb 2, 2023

      Healthy Subjects Trial in Overland Park (Trans-Sodium Crocetinate, Placebo)

      Completed
      • Healthy Subjects
      • Trans-Sodium Crocetinate
      • Placebo
      • Overland Park, Kansas
        Altasciences Clinical Kansas Inc
      Aug 20, 2021

      HIV/AIDS, Trauma Trial in Boston, Toronto (CBT-TSC, Life Steps and Sexual Decision-Making)

      Completed
      • HIV/AIDS
      • Trauma
      • CBT-TSC
      • Life Steps and Sexual Decision-Making
      • Boston, Massachusetts
      • +1 more
      Apr 7, 2023

      Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

      Recruiting
      • Recurrent Low Grade Astrocytoma
      • +4 more
      • Quality-of-Life Assessment
      • +3 more
      • Birmingham, Alabama
      • +64 more
      Aug 20, 2022